Venous thromboembolism risk varies across hormonal contraceptives, according to a research letter published in JAMA.

The population of interest in our study included a very broad range of medical patients, and not just those with high-risk conditions. The risk among patients with known risk factors for VTE ...

A fuller picture of protein S deficiency emerged with large-scale research showing the immense thrombotic risks faced by carriers of rare loss-of-function gene variants, though patients with ...

Lung cancer can increase the risk of blood clots inside your deep veins. This is called venous thromboembolism (VTE). People with cancer are 4 to 7 times more likely to develop a clot than people ...

A new study from Denmark has found that men who use anabolic androgenic steroids (AAS) have a much higher risk of developing ...

The System is designed to treat VTE more safely and effectively, and at a lower cost to the health care system than currently approved therapies. SonoThrombectomy treatment was highly effective in ...

"Venous thromboembolism, which include pulmonary ... The current subpopulation analysis included 12,211 patients in 11 high-risk groups -- head injury and an AIS score >2 (n=371), abdominal ...

Multivariate analysis identified elevated D-dimer levels (>750 ng/ml) and reduced serum albumin as independent risk factors ...

Venous Thromboembolism Treatment Market The venous Thromboembolism Treatment Market growth is driven by rising VTE prevalence, anticoagulan ...